Hagop Youssoufian appointed as Chief Medical Advisor at Kojin Therapeutics

Hagop Youssoufian is the Founder and Principal of Youssoufian Consulting. He serves as an Advisory Board Member at AffyImmune Therapeutics and is a Co-Founder of SOLID Therapeutics.

Additionally, he holds the position of Adjunct Professor of Medicine at Brown University. Youssoufian is also a member of the Clinical Advisory Board at C4 Therapeutics, where he previously served as Interim Chief Medical Officer (CMO).

Hagop Youssoufian recently stepped into the position of Chief Medical Advisor at Kojin Therapeutics.

On this occasion, Kojin Therapeutics shared a post on LinkedIn:

“We welcome Hagop Youssoufian, M.D. as our Chief Medical Advisor and a member of our evolving leadership team.

Hagop is a distinguished physician-scientist and drug-development professional with over 35-years of experience in academia and industry – including biotech and big pharma companies. He has overseen more than 100 INDs and 500 clinical trials involving new medicines for solid tumors and hematologic malignancies.

He is setting in motion plans for biomarker-enriched clinical trials of our first ferroptosis medicines. Although Hagop finds it difficult to accept the notion of spare time, he nevertheless manages to be a loud cheerleader for Manchester City F.C. and its winning culture in the English Premier League.”

More posts featuring Hagop Youssoufian.